logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: research
Load new posts () and activity
Like Reblog Comment
review 2018-05-01 11:56
Vaccine Adjuvants Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Immunization adjuvants are the substances added to the antibodies for improving the antibody capacity to secure against the disease. Immunization adjuvants enhance the immunogenicity of cleaned antigens, which has immunostimulatory abilities and has been utilized as a part of the antibodies for over 90 years. These days, a less number of antibody adjuvants are accessible, for example, MF 59 and aluminum salts. Immunizations are joined with the adjuvants to guarantee body creates an effective resistant reaction to secure the individual against the disease.

 

Increment in the pervasiveness of different zoonotic and different irresistible maladies, increment in the interest for enhanced inoculation against different sicknesses, government concentrate on sorting out the vaccination programs, an expansion in the utilization of engineered and recombinant antibodies foreseen to impel the immunization adjuvants advertise over the estimate time frame. Moreover, increment in the predominance of domesticated animals and partner creature illnesses, innovative headways in the aluminum hydroxide adjuvants, and government bolster for R&D exercises are foreseen to fuel the immunization adjuvants advertise over the conjecture time frame. In any case, stringent administrative arrangements, symptoms related with the adjuvants use, and high cost for the R&D exercises may obstruct the development of antibody adjuvants showcase over the estimate time frame.

 

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-vaccine-adjuvants-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Vaccine adjuvants market is segmented on the basis of product type, vaccine type, route of administration, application, and end user

 

Based on the product type, vaccine adjuvants market is segmented into the following:

  • Pathogen components
  • Combination adjuvants
  • Particulate adjuvants
  • Adjuvant emulsions
  • Others

 

Based on the vaccine type, vaccine adjuvants market is segmented into the following:

  • Human vaccines
  • Veterinary vaccines

 

Based on the route of administration, vaccine adjuvants market is segmented into the following:

  • Oral
  • Mucosal
  • Parenteral
  • Others

 

Based on application, vaccine adjuvants market is segmented into the following:

  • Infectious diseases
  • Cancer
  • Others

 

Based on the end user, vaccine adjuvants market is segmented into the following:

  • Pharmaceutical industries
  • Biotechnology industries
  • Veterinary vaccine manufacturing industries

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-vaccine-adjuvants-market/#ulp-c654SbFYO64MsOhu

 

 

Vaccine adjuvants market is growing at a significant CAGR owing to increase in the prevalence of infectious diseases in humans, livestock & companion animals around the globe. Growing need for enhancing immune response and limited immunogenicity of novel vaccines expected to fuel the vaccine adjuvants market. Acquisitions and mergers, collaborations, and novel adjuvant introductions are the strategies applied by the market players to dominate the vaccine adjuvants market. For instance, in August 2013, FDA approved the Sequirus’s Afluria quadrivalent vaccine for people with 18 years or older. Similarly, funding by the government organizations to augment adjuvants research is anticipated to boost the vaccine adjuvants market. For instance, in April 2016, National Institute of Allergy and Infectious Diseases awarded 6 grants to various organizations including universities such as University of Wisconsin about US$ 3.1 Mn grants for vaccine adjuvants research.

 

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-vaccine-adjuvants-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically, vaccine adjuvants market is segmented into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. North America is expected to hold a major share in vaccine adjuvants market owing to rise in the incidence of infectious diseases, government initiatives for organizing immunization programs, an increase in the collaborations for R&D activities on vaccine adjuvants are fuelling the market. For instance, in July 2016, U.S. Army Medical Research Institute of Infectious Diseases has collaborated with China’s Jilin Jian Yisheng Biopharma for the development of Ebola PIKA adjuvant vaccine. Europe holds a significant share in vaccine adjuvants market owing to rising in the prevalence of cancer, influenza, and other infectious diseases, increase the awareness about the vaccine adjuvant applications in the manufacturing of vaccines, and rise in the R&D activities are expected to propel the market growth. Asia Pacific vaccine adjuvants market is growing significantly due to rise in birth rate, increase in the prevalence of various infectious diseases, and development of newer adjuvants for improving the vaccine immunization.

 

 

Some of the players in vaccine adjuvants market are Invivogen (U.S.), MVP Laboratories, Inc. (U.S.), CSL Limited (Australia), SEPPIC (France), Brenntag Biosector (Denmark), Novavax, Inc. (U.S.), Agenus, Inc. (U.S.), OZ Biosciences (France), and Jilin Jian Yisheng Biopharma Co. Ltd. (China) to name a few.

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-vaccine-adjuvants-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised which follow a holistic approach to solve needs of market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

 

Source: www.precisionbusinessinsights.com/market-reports/global-vaccine-adjuvants-market
Like Reblog Comment
review 2018-05-01 11:55
Global Uveitis Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Uveitis is the term that describes group of inflammatory diseases that affect eye and produces swelling. Uveitis can reduce sight and may cause vision loss. Causes of uveitis include infections such as brucellosis, leptospirosis, syphilis, tuberculosis, autoimmune diseases such as sarcoidosis, crohn’s disease, multiple sclerosis, arthritis, ankylosing spondylitis, and psoriatic arthritis. In addition, uveitis is also caused by drugs such as rifabutin and moxifloxacin. Uveitis affects uvea, lens, retina, optic nerve, and vitreous. Uveitis can be classified into anterior uveitis, intermediate uveitis, posterior uveitis and pan-uveitis based on part of inflammation.

 

The main driver for the growth of uveitis market is rise in prevalence and complications related to uveitis. In addition, increase in prevalence rates, market players betting heavily on research and development to develop new drugs, introduction of biologics into the market, fast approval of the drugs are fuelling the market growth of uveitis treatment market. According to the Ocular Immunology and Uveitis Foundation, worldwide 2,359,242 people are estimated to have the disorder. Even there are significant advances in research and therapeutics, prevalence of blindness secondary to uveitis has not been reduced in the past thirty years. However, few factors are restraining the growth of the market such as side effects of the drugs, eye irritation and lack of awareness about eye disorders in undeveloped regions, lack of sufficient healthcare infrastructure are hindering the uveitis treatment system market.

 

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-uveitis-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Uveitis treatment market segmented based on drug class, disease type, by cause and distribution channel

 

Based on drug class, uveitis treatment market is segmented into

  • Corticosteroids
  • Immunosuppressant
  • Monoclonal antibodies
  • Antibiotics
  • Antivirals
  • Antifungal
  • Analgesics

 

Based on disease type, uveitis treatment market is segmented into

  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis

 

Based on cause, uveitis treatment market is segmented into

  • Infectious Uveitis
  • Non-Infectious Uveitis

 

Based on distribution channel, uveitis treatment market is segmented into

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-uveitis-treatment-market/#ulp-c654SbFYO64MsOhu

 

 

Market players are developing novel molecules that can treat uveitis conditions in order to enhance their sales revenue. Companies are focusing on the development of the various drugs in the treatment of the uveitis. For instance, Aurinia Pharmaceuticals Inc. developing luveniq, a calcineurin inhibitor for the treatment of noninfectious uveitis. Recently it has completed its phase-II clinical trials. Similarly, other pipeline drugs such as EMEA, DE-109, Gevokizumab, Peptide B27PD are being developed by different companies. Considering the aforementioned factors global uveitis treatment market is expected to grow at significant rate during forecast period.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-uveitis-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically uveitis treatment market segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is leading in uveitis treatment market due to various factors such as early approval of drugs compared to other regions, increased R&D investments by market players, and high prevalence of the uveitis are contributing growth of the market. In Europe region due to increased prevalence of diseases such as HIV, multiple sclerosis that are underlying causes of uveitis conditions. Japan, China, and India are expected to play important role in the revenue growth of the Asia-Pacific uveitis treatment market. China and India market growth is due to rapidly developing healthcare infrastructure, increased research and development expenditure and growing awareness about the eye related diseases. However, manufacturing of eye preparations required aseptic conditions and the manufacturing plant should be GMP certified. Hence the cost related to these preparations are very high that have direct implication on cost of the drugs.

 

Some of the players in uveitis treatment market include AbbVie Inc. (U.S.), Eyegate Pharmaceuticals Inc. (US), Valeant Pharmaceuticals (Bausch + Lomb) (Canada), Novartis AG (Switzerland), Alimera Sciences Inc. (U.S.) and Santen Pharmaceutical Co. Ltd (Japan) to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-uveitis-treatment-market/

 

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

Source: www.precisionbusinessinsights.com/market-reports/global-uveitis-treatment-market
Like Reblog Comment
review 2018-05-01 11:34
Global Transcatheter Heart Valve (THV) Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Transcatheter heart valves (THV) are used to replace the heart valves with a prosthetic valve for treatment of severe aortic stenosis and mitral regurgitation. These heart valve diseases can be congenital or acquired later in life due to age related life style changes and may be other underlying diseases. If these are not treated can cause heart failure, stroke, blood clots, or death due to sudden cardiac arrest.

 According to WHO, by 2050, the world’s population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015, who are more susceptible to the valve heart disease. The prime driver for the transcatheter heart valves (THV) market is rising demand for less invasive procedure for high-risk patients such as patients having multiple chronic diseases, growing prevalence of heart valve disorders. Moreover, increased incidences of heart diseases and technological advances in transcatheter heart valves (THV) driving the market. However, high costs of transcatheter heart valves, associated risks in implantation of transcatheter, slipping of valves, and misplacement of catheters are decreasing the acceptance in patients and affecting the market growth negatively.

 

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-transcatheter-heart-valve-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Transcatheter heart valve (THV) market segmented on the basis of product type, by approach, and end-user

 

By product type, transcatheter heart valve market segmented into

  • Trans Catheter Aortic Valve Replacement
  • Trans Catheter Mitral Valve Repair

 

By surgical procedure type, transcatheter heart valve market segmented into

  • Trans femoral Approach
  • Trans apical Approach
  • Trans aortic Approach

 

By end-user, transcatheter heart valve market segmented into

  • Hospitals
  • Ambulatory Surgical Centres
  • Cardiac Catheterization Laboratory

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-transcatheter-heart-valve-market/#ulp-c654SbFYO64MsOhu

 

 

Transcatheter heart valve (THV) market is anticipated to grow at significant CAGR over the forecast period. Market players are focusing on investments in R&D to develop and launch various new and technologically advanced devices for making heart valve procedures safer and more effective and strengthening their positions in market. For instance, transcatheter aortic valve replacement or trans catheter aortic valve implantation has become novel procedures for patients who are considered high risk for standard valve replacement therapy. Apart from this, companies also focusing on mergers and acquisitions to enhance their market share. For instance in 2016, Edwards Lifesciences Corporation agreed to acquire Valtech Cardio Ltd., for trans catheter repair of mitral and tricuspid valves.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-transcatheter-heart-valve-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically transcatheter heart valve market segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America market is dominating among all regions. Over five million people in U.S. are diagnosed with heart valve disease each year. Europe market for transcatheter heart valves expected to grow at significant rate due to technological advancements, increase in awareness and acceptance of novel replacement devices for cardiac disorders. Emerging economies of Asia-Pacific region such as China and India expected to show significant growth in the market due to medical tourism, increasing patients with heart diseases and significant changing in lifestyle.

 

Some of the players in trans catheter market include Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), and Medtronic (U.S) to name a few

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-transcatheter-heart-valve-market/

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

 

 

 

 

Source: www.precisionbusinessinsights.com/market-reports/global-transcatheter-heart-valve-market
Like Reblog Comment
review 2018-05-01 11:33
Global Therapeutic Vaccines Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Therapeutic vaccines are biological combinations which develop immunity against a diseased tissue or cell. Therapeutic vaccines are administered to the patient in order to induce a defence mechanism against particular disease. These are developed to treat various cancer diseases, HIV, and Alzheimer’s disease etc. Prophylactic vaccines differ from therapeutic vaccines are used for the prevention and control of diseases, while the prophylactic vaccines are only used for prevention of diseases. Therapeutic vaccines are specially manufactured for the HIV positive individuals with the healthy immune system, to increase the ability to fight against microorganisms. Therapeutic vaccines are currently developed for chronic viral infections, such as human immunodeficiency virus (HIV), human papillomavirus (HPV), herpes simplex virus (HSV), cancer, hepatitis B virus, and hepatitis C virus etc. as an alternative to antiviral treatment.

 Global Market Outline: Therapeutic Vaccines Market

 The global therapeutic vaccines market is expected to grow at a significant CAGR due to increase in the prevalence of chronic diseases such as cancer, and HIV etc. According to World Health Organisation, an escalation of the diseases such as cancer (approximately 8.8 Mn people died in 2015) and HIV expected to drive the growth of global therapeutic vaccines market over the forecasting period. The advanced and active R&D activities for therapeutic vaccines by pharmaceutical companies for various types of cancers are in pipeline which is expected to create potential opportunity in the global therapeutic vaccines market in future. Apart from this, rising number of mergers and acquisitions, and an increase in funding from government for development of therapeutic vaccines might fuel the growth of global therapeutic vaccines market over the forecasting period. However, inefficient research and development and non-existent reimbursement policies for vaccines are the primary factors which are expected to hinder the growth of global therapeutic vaccines market. Similarly, stringent regulatory implications, higher cost of vaccines, lesser accessibility to the vaccines, availability of alternative treatments for the diseases, and some adverse effects associated with the vaccines might hamper the growth of global therapeutic vaccines market over the forecast period.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-therapeutic-vaccines-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Global therapeutic vaccines market has been segmented on the basis of product type, application, technologies, market type, and end user

 

Based on product type, global therapeutic vaccines market has been segmented into the following:

  • Conjugate vaccines
  • Live attenuated vaccines
  • Inactivated and subunit vaccines
  • Toxoid vaccines
  • Recombinant vaccines

 

Based on application, global therapeutic vaccines market has been segmented into the following:

  • Infectious Diseases
  • Oncology
  • Addiction
  • Autoimmune diseases
  • Neurological diseases
  • Others

 

Based on technology, global therapeutic vaccines market has been segmented into the following:

  • Autologous vaccines
  • Allogeneic vaccines

 

Based on the valency, global therapeutic vaccines market has been segmented into the following:

  • Monovalent vaccines
  • Multivalent vaccines

 

Based on the end-user, global therapeutic vaccines market has been segmented into the following:

  • Hospitals
  • Clinic
  • Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-therapeutic-vaccines-market/#ulp-c654SbFYO64MsOhu

 

 

The global therapeutic vaccines market is in the nascent stage where many players are actively involved in the development of therapeutic vaccines. Few companies have adopted some key business strategies, such as product innovation, and new product launching to ensure their dominance in the global therapeutic vaccines market. The global therapeutic vaccines market is positively affected by the significant rise in prevalence of chronic diseases such as cancer, and HIV etc. Few companies have taken an active lead in research and development of therapeutic vaccines. For instance, in April 2010, Dendreon Corporation, launched FDA approved immunotherapy drug Provenge, for the treatment of prostate cancer. According to U.S. Department of Health and Human Services, there are some vaccines in the clinical trial stage, such as Lucanix (Belagenpumatucel-L), gp100 melanoma vaccine, for Non-small cell lung cancer. Similarly, Merck & Co., Inc. and GSK Plc. are expected to launch vaccines such as GSK1572932A, and GV1001 having entered phase 3 trials.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-therapeutic-vaccines-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically, the global therapeutic vaccines market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounts for the largest share in global therapeutic vaccines market followed by Europe and Asia-Pacific. In North-America, U.S. contributes the largest share in global therapeutic vaccines market (according to U.S. Centres for Disease Control and Prevention (CDC), therapeutic vaccines can suppress almost 10 infectious diseases in U.S. by up to 90%). Rising technology support for the development of new vaccines and well-developed healthcare infrastructure expected to fuel the growth of therapeutic vaccines market in North-America region. Europe, which currently stands at the second position in global therapeutic vaccines market, and is expected to show a significant growth due to the increase in the number of patients with chronic diseases. Asia-Pacific region expected to grow at a significant rate due to rising prevalence of various infectious and chronic diseases and aging population. Large investments in the field of research and development and increasing medical tourism in Asian countries might fuel the growth of therapeutic vaccine market in the Asia-pacific region. Latin America is another important regional market, which offers vast opportunities for the players entering into this market, and is expected to grow moderately due to the high cost of therapeutic vaccines.

 

Some of the players in global therapeutic vaccines market are Merck & Co., Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Sanofi-Pasteur (France), Dendreon (U.S.). Agenus Inc. (U.S.), Valeant (Canada), Bavarian Nordic (Denmark), Pfizer, Inc. (U.S.) and Inovio Pharmaceuticals, Inc. (U.S.), to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-therapeutic-vaccines-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

Source: www.precisionbusinessinsights.com/market-reports/global-therapeutic-vaccines-market
Like Reblog Comment
review 2018-05-01 07:50
Therapeutic Drug Monitoring Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Global Therapeutic Drug Monitoring Market: By Product (Equipment (Proteomics Equipment, Immuno Assay Analysers and Others) and Consumables), By Drug class (Antibiotics, Immunosuppressant’s, Anti-Epileptic Drugs, Psychoactive Drugs, Anti-Arrhythmic Drugs and Others), By end user (Hospitals, Clinical Laboratories and Others) By Geography – Therapeutic Drug Monitoring Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

 

Market Outline: Global Therapeutic Drug Monitoring Market

Therapeutic drug monitoring refers to the monitoring of drug concentrations in the body fluids, usually plasma, during the treatment or diagnosis of the condition or disease. The therapeutic drug monitoring is done for the specific drugs only because many drugs are not clearly related to their effects. The therapeutic drug monitoring aims to reduce the toxicity assisted with diagnosis or helps to enhance the drug efficiency. Some of the drugs have narrow therapeutic window. If the concentration is above the upper limit, it shows toxic effects. If the drug is below the lower level, it will not show therapeutic effect. Especially, for these type of drugs, therapeutic drug monitoring is used. Therapeutic drug monitoring helps the physicians to optimise the drug for getting the therapeutic outcome.

 

Market dynamics: Global Therapeutic Drug Monitoring Market

Global therapeutic drug monitoring is mainly driven by the rise in demand for the administration of personalized dosage of the medicine and technological advancements in tests that are used to monitor the drug therapeutics. In addition, prevalence of the psychiatric diseases and cancer which need the drug monitoring for the optimum therapeutic outcomes and advantages such as dose optimisation and applications in personalized medicine expected to boost the therapeutic drug monitoring market over the forecast period. Furthermore, advent of biomarker identification for cancer diagnostics expected to benefit the growth of global therapeutic drug monitoring market. However, high costs and lack of skilled professionals may hamper the global therapeutic drug monitoring market over coming years.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-therapeutic-drug-monitoring-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Global Therapeutic Drug Monitoring Market

Global Therapeutic Drug Monitoring market is segmented based on products, drug class, and end user

Based on product, global therapeutic drug monitoring market is segmented into

  • Equipment
    • Proteomics Equipment
    • Immuno Assay Analysers
    • Others
  • Consumables

Based on drug class, global therapeutic drug monitoring market is segmented into

  • Antibiotics
  • Immunosuppressant’s
  • Anti-Epileptic Drugs
  • Psychoactive Drugs
  • Anti-Arrhythmic Drugs
  • Others

Based on end user, global therapeutic drug monitoring market is segmented into

  • Hospitals
  • Clinical Laboratories
  • Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-therapeutic-drug-monitoring-market/#ulp-c654SbFYO64MsOhu

 

Market Summary: Global Therapeutic Drug Monitoring Market

Global therapeutic drug monitoring devices market expected to grow at significant rates owing to the rise in prevalence of neuronal disorders and cancers worldwide. According to World Health Organization (WHO), about 50 Mn people have epilepsy worldwide and 80% of people from low and middle-income countries. Companies operating in global therapeutic monitoring market are developing new innovative products and gaining the competitive advantage. For instance, in September 2012, Bruker Corporation launched Toxtyper, an automated clinical spectroscopy solution for toxicology laboratories in Europe. Toxtyper is faster and reliable solution for the toxics and abusive drug monitoring. Furthermore, companies are adopting the merger and acquisition strategies to strengthen its product portfolio and increase their market position.

 

Regional Analysis: Global Therapeutic Drug Monitoring Market

Geographically therapeutic drug monitoring market is divided into five key regions, i.e. North America, Europe, Asia- Pacific, Latin America, and The Middle East & Africa. North America expected to have the major market share in global therapeutic drug monitoring owing to the rise in demand for metabolomics studies and high rate of organ transplantation. In addition, growth in the pharmacodynamics and kinetic studies for the dosage optimisation and growth in demand for the personalized medicine expected to boost the North America therapeutic drug monitoring market over the forecast period. Asia Pacific is expected to have the rapid growth rate owing to developing healthcare infrastructure, rise in R&D investments. Europe therapeutic drug monitoring market expected to have notable growth rate over the coming years due to rise in demand for personalized medicine and presence of key market players in the region.

 

Competition Assessment: Global Therapeutic Drug Monitoring Market

Key player’s profiles in global therapeutic drug monitoring market include

  • Beckman Coulter Inc. (U.S.)
  • Hoffmann-La Roche (U.S.)
  • Bio-Rad Laboratories Inc. (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • Siemens Healthineers (Siemens AG (Germany)
  • Alere Inc. (U.S.)
  • Diagnostics GmbH (Germany)
  • BÜHLMANN Laboratories AG (Germany)
  • bioMérieux (U.S.)
  • Merck Millipore (E. Merck KG) (Germany)
  • DiaSorin (Italy)
  • Myriad Genetics (U.S.)
  • Miraca Life Sciences (Miraca Holdings Inc.) (Japan)

 

Notable Market Developments: Global Therapeutic Drug Monitoring Market

  • In January 2016, BÜHLMANN launched Quantum Blue Infliximab trough level rapid test for plasma level monitoring of TNF-alpha monoclonal antibody for IBD patients.
  • In July 2015, Bio-Techne Corporation acquired Cliniqa Corporation to strengthen its portfolio and market position.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-therapeutic-drug-monitoring-market/#ulp-14mlyhjMGhVjZqa3

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

 

Get access to full summary @

 

https://www.precisionbusinessinsights.com/market-reports/global-therapeutic-drug-monitoring-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

Source: www.precisionbusinessinsights.com/market-reports/global-therapeutic-drug-monitoring-market
More posts
Your Dashboard view:
Need help?